社会福祉法人 三井記念病院は、東京都千代田区神田和泉町に所在する医療機関である。 三井家が創設したが、目的は三井財閥や三井グループの福利厚生ではなく、貧困者対象の無料施療機関であった。現在は一般の保険医療機関で、各学会の専門医認定施設である。

During the past decade, Mitsui Memorial Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mitsui Memorial Hospital" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Medtronic Vascular" with 3 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "JIMRO Co., Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mitsui Memorial Hospital" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Teikyo University" with 1 trials as a collaborator and "Tokai University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Mitsui Memorial Hospital" are "Cardiovascular Diseases" (3 trials), "Hypertension" (3 trials), "Ulcerative Colitis" (3 trials), "Vascular Diseases" (3 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Mitsui Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Mitsui Memorial Hospital" are "Device" (9 trials), "Drug" (7 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Mirikizumab" (2 trials), "Sham Procedure" (2 trials), "Symplicity Spyral™ multi-electrode renal denervation system" (2 trials) and "3 months of dual antiplatelet therapy (DAPT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mitsui Memorial Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Mitsui Memorial Hospital". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Mitsui Memorial Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mitsui Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".